stars 1 stars 2 stars 3

Our mission is to transform the lives of people living with rare diseases and devastating conditions through the development and delivery of innovative medicines, as well as through supportive technologies and healthcare services. By continuing to deepen our understanding of rare disease, which began with our pioneering work in complement biology, we are able to innovate and evolve into new areas where there is great unmet need and opportunity to help patients and families fully live their best lives. Our culture is rooted in integrity, inclusiveness, and our dedication to joining and supporting the communities in which we live and work. We invest in and value people who believe in the importance of our purpose and understand what it takes to deliver on it. Alexion has over 3,000 talented colleagues dedicated to serving people living with rare diseases in more than 50 countries around the world. Our global headquarters are based in Boston, Massachusetts and our EMEA headquarters are in Zürich, Switzerland. We also have a Research Center of Excellence in New Haven, Connecticut, global supply chain and operations headquarters in Ireland, as well as local and regional operations in countries around the world. At Alexion, our passion drives us to continuously innovate and create meaningful value in all we do. In doing so, we change lives for the better – ours, people living with rare diseases, and the communities we serve. Every day. Community Guidelines:

View Top Employees from Alexion Pharmaceuticals, Inc.
Revenue $6.1 billion
Funding $18 million
Employees 6,081 (6,081 on RocketReach)
Founded 1992
Address 121 Seaport Blvd, Boston, Massachusetts 02210, US
Phone (475) 230-2596
Fax (203) 271-8198
JavaScript, HTML, PHP +288 more (view full list)
Category Biotechnology, Pharmaceuticals, Biotechnology Research, Healthcare, Science and Engineering, Biopharmaceutical, Health Care, Complement Inhibition, Medical, Metabolic Disorders, Neurology, Rare Diseases, Research and Development, Transplant, Haematology, Nephrology
Competitors Avanir Pharmaceuticals, Biogen, Ultragenyx Brasil, United Therapeutics Corporation, Vertex Pharmaceuticals
SIC 283, 28
NAICS 325, 541, 32541, 32, 3254, 54

Alexion Pharmaceuticals, Inc. Questions

The Alexion Pharmaceuticals, Inc. annual revenue was $6.1 billion in 2023.

Sean Christie is the CFO of Alexion Pharmaceuticals, Inc..

6,081 people are employed at Alexion Pharmaceuticals, Inc..

Alexion Pharmaceuticals, Inc. is based in Boston, Massachusetts.

The NAICS codes for Alexion Pharmaceuticals, Inc. are [325, 541, 32541, 32, 3254, 54].

The SIC codes for Alexion Pharmaceuticals, Inc. are [283, 28].

Top Alexion Pharmaceuticals, Inc. Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
G2Crowd Trusted
300K+ Plugin Users